Amarantus Bioscience Holdings, Inc. — Form D

Amarantus Bioscience Holdings, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-17. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
David LoweDirectorWalnut Creek, CA
Iain RossDirectorLondon, X0
MARC FAERBERExecutive OfficerSANTA CRUZ, CA
Robert FarrellExecutive OfficerNew York, NY
Robert HarrisDirectorPotomac, MD
Gerald CommissiongDirectorSan Francisco, CA
Gerald CommissiongExecutive OfficerSan Francisco, CA
Donald HuffmanDirectorSan Francisco, CA
John CommissiongDirectorSan Francisco, CA
John CommissiongExecutive OfficerSan Francisco, CA
Steven SpenceDirectorSan Francisco, CA
Robert L HarrisDirectorDallas, TX
Robert E HarrisDirectorSUNNYVALE, CA
Marc E FaerberExecutive OfficerSUNNYVALE, CA
Gerald E CommissiongDirectorSUNNYVALE, CA
Gerald E CommissiongExecutive OfficerSUNNYVALE, CA
Mark E BenedykDirectorSUNNYVALE, CA
Dr. John W CommissiongDirectorSUNNYVALE, CA
Dr. John W CommissiongExecutive OfficerSUNNYVALE, CA
Mark L BenedykDirectorSunnyvale, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2018-03-12D$1.5M$300K
2013-09-13D$5.0M$1.4M
2013-08-28D$1.3M$1.3M

More